PRM Proteome Sciences plc

0.0128USD0.9700 GBp · LSE-17.09%Mkt Cap: 4.47M USDP/E: —

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The compa…

Key Statistics

Company
Market Cap4.47M USD
Enterprise Value24.79M USD
Revenue (TTM)4.96M USD
Gross Profit-106.53K USD
Net Income (TTM)-4.03M USD
Revenue/Share0.02 USD
Last Price0.0128 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISINGB0003104196
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.23
EV/Revenue5.00
P/S0.90
P/B-0.33
EPS (TTM)-0.01 USD
EPS (Forward)—
52W Range
0.01320% of range0.0579
52W High0.0579 USD
52W Low0.0132 USD
Profitability
Gross Margin-2.16%
Oper. Margin-60.56%
EBITDA Margin-54.16%
Profit Margin-81.50%
ROE32.12%
ROA-37.08%
ROIC-41.64%
ROCE—
Growth
Revenue Growth0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-60.50K USD
CapEx (TTM)127.57K USD
FCF Margin-9.32%
FCF Yield-10.33%
Net Debt19.53M USD
Net Debt/EBITDA-7.27
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.65
Current Ratio0.12
Quick Ratio0.09
Book Value/Sh-0.04 USD
Cash/Share0.0039 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.350.72M
Float219.76M
Insiders18.52%
Institutions24.80%
Technical
SMA 500.0185 (-31.0%)
SMA 2000.0210 (-39.3%)
Beta0.21
S&P 52W Chg12.00%
Avg Vol (30d)172.84K
Avg Vol (10d)106.36K
Technical Indicators
RSI (14)27.2
MACD-0.0646
MACD Signal-0.0273
MACD Hist.-0.0373
BB Upper0.0212 USD
BB Middle0.0180 USD
BB Lower0.0147 USD
BB Width36.18%
ATR (14)0.0048 USD
Vol Ratio (20d)4.99x

About Proteome Sciences (LON: PRM)

›

Proteome Sciences (LON: PRM) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 0.9700 GBp on 20 November 2026, down 37.4% over 52 weeks. Its 52-week range is 1.000 GBp to 4.400 GBp, and it trades at the bottom of that range.

Its market capitalisation is 3.40M GBP.

Proteome Sciences reports return on equity of 32.1%, an operating margin of -60.6% and revenue up 0.8% year over year.

Its debt exceeds its cash by 14.85M GBP. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.